Authors:
Mor, M
Spadoni, G
Di Giacomo, B
Diamantini, G
Bedini, A
Tarzia, G
Plazzi, PV
Rivara, S
Nonno, R
Lucini, V
Pannacci, M
Fraschini, F
Stankov, BM
Citation: M. Mor et al., Synthesis, pharmacological characterization and QSAR studies on 2-substituted indole melatonin receptor ligands, BIO MED CH, 9(4), 2001, pp. 1045-1057
Authors:
Spadoni, G
Balsamini, C
Diamantini, G
Tontini, A
Tarzia, G
Mor, M
Rivara, S
Plazzi, PV
Nonno, R
Lucini, V
Pannacci, M
Fraschini, F
Stankov, BM
Citation: G. Spadoni et al., 2-N-acylaminoalkylindoles: Design and quantitative structure-activity relationship studies leading to MT2-selective melatonin antagonists, J MED CHEM, 44(18), 2001, pp. 2900-2912
Authors:
Bello, L
Carrabba, G
Giussani, C
Lucini, V
Cerutti, F
Scaglione, F
Landre, J
Pluderi, M
Tomei, G
Villani, R
Carroll, RS
Black, PM
Bikfalvi, A
Citation: L. Bello et al., Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo, CANCER RES, 61(20), 2001, pp. 7501-7506
Authors:
Nonno, R
Pannacci, M
Lucini, V
Angeloni, D
Fraschini, F
Stankov, BM
Citation: R. Nonno et al., Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt(1)-antagonists, BR J PHARM, 127(5), 1999, pp. 1288-1294
Authors:
Spadoni, G
Balsamini, C
Bedini, A
Carey, A
Diamantini, G
Di Giacomo, B
Tontini, A
Tarzia, G
Nonno, R
Lucini, V
Pannacci, M
Stankov, BM
Fraschini, F
Citation: G. Spadoni et al., N-acyl-5- and -2,5-substituted tryptamines: Synthesis, activity and affinity for human mt(1) and MT2 melatonin receptors, MED CHEM RE, 8(9), 1998, pp. 487-498
Authors:
Leone, M
Lucini, V
D'Amico, D
Grazzi, L
Moschiano, F
Fraschini, F
Bussone, G
Citation: M. Leone et al., Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache, CEPHALALGIA, 18(10), 1998, pp. 664-667